PMC:7558914 / 818-1168 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"39","span":{"begin":82,"end":90},"obj":"Species"},{"id":"46","span":{"begin":1,"end":20},"obj":"Chemical"},{"id":"47","span":{"begin":172,"end":190},"obj":"Chemical"},{"id":"48","span":{"begin":196,"end":208},"obj":"Chemical"},{"id":"49","span":{"begin":220,"end":238},"obj":"Chemical"},{"id":"50","span":{"begin":244,"end":263},"obj":"Chemical"},{"id":"51","span":{"begin":299,"end":317},"obj":"Chemical"},{"id":"52","span":{"begin":322,"end":341},"obj":"Chemical"},{"id":"67","span":{"begin":114,"end":124},"obj":"Disease"}],"attributes":[{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"MESH:C558899"},{"id":"A47","pred":"tao:has_database_id","subj":"47","obj":"MESH:D006886"},{"id":"A48","pred":"tao:has_database_id","subj":"48","obj":"MESH:D017963"},{"id":"A49","pred":"tao:has_database_id","subj":"49","obj":"MESH:D006886"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"MESH:C558899"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"MESH:D006886"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:C558899"},{"id":"A67","pred":"tao:has_database_id","subj":"67","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was different antiviral combinations including hydroxychloroquine plus azithromycin (93.3%) or hydroxychloroquine plus lopinavir/ritonavir (79.9%). Different combinations of hydroxychloroquine and lopinavir/ritonavir (46.7%) "}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":114,"end":124},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":" lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was different antiviral combinations including hydroxychloroquine plus azithromycin (93.3%) or hydroxychloroquine plus lopinavir/ritonavir (79.9%). Different combinations of hydroxychloroquine and lopinavir/ritonavir (46.7%) "}

{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":52,"end":272},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" lopinavir/ritonavir was found in 40% of protocols. The recommended treatment for patients with mild and moderate pneumonias was different antiviral combinations including hydroxychloroquine plus azithromycin (93.3%) or hydroxychloroquine plus lopinavir/ritonavir (79.9%). Different combinations of hydroxychloroquine and lopinavir/ritonavir (46.7%) "}